GLAXO SMITH KLINEGLAXO SMITH KLINEGLAXO SMITH KLINE

GLAXO SMITH KLINE

No trades
See on Supercharts
Market capitalization
‪2.84 B‬EGP
‪2.43 M‬
Beta (1Y)
0.29

About GLAXO SMITH KLINE

Headquarters
Cairo
Founded
1981
Website
ISIN
EGS38171C012
FIGI
BBG000C181F6
GlaxoSmithKline (Egypt) engages in the pharmaceutical and healthcare business. Its business operations are carried out through the production, packaging, marketing, sale, and distribution of medicines and other pharmaceutical products. The company was founded on January 14, 1981 and is headquartered in Cairo, Egypt.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BIOC is 32.370 EGP — it has decreased by 4.32% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange GLAXO SMITH KLINE stocks are traded under the ticker BIOC.
GLAXO SMITH KLINE is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
BIOC stock is 13.16% volatile and has beta coefficient of 0.29. Check out the list of the most volatile stocks — is GLAXO SMITH KLINE there?
Yes, you can track GLAXO SMITH KLINE financials in yearly and quarterly reports right on TradingView.
BIOC stock has risen by 7.79% compared to the previous week, the month change is a 10.40% rise, over the last year GLAXO SMITH KLINE has showed a 10.68% decrease.
BIOC net income for the last quarter is ‪27.16 M‬ EGP, while the quarter before that showed ‪5.76 M‬ EGP of net income which accounts for 371.30% change. Track more GLAXO SMITH KLINE financial stats to get the full picture.
Today GLAXO SMITH KLINE has the market capitalization of ‪2.70 B‬, it has increased by 4.36% over the last week.
Yes, BIOC dividends are paid annually. The last dividend per share was 0.75 EGP. As of today, Dividend Yield (TTM)% is 2.32%. Tracking GLAXO SMITH KLINE dividends might help you take more informed decisions.
Like other stocks, BIOC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLAXO SMITH KLINE stock right from TradingView charts — choose your broker and connect to your account.
BIOC reached its all-time high on Feb 21, 2024 with the price of 47.500 EGP, and its all-time low was 5.770 EGP and was reached on Mar 18, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLAXO SMITH KLINE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLAXO SMITH KLINE stock shows the buy signal. See more of GLAXO SMITH KLINE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.